Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand

BACKGROUND: Dihydroartemisinin-piperaquine (DHA-PPQ) combination therapy is the current first-line treatment for Plasmodium falciparum malaria in Thailand. Since its introduction in 2015, resistance to this drug combination has emerged in the eastern part of the Greater Mekong Subregion including th...

Descripción completa

Detalles Bibliográficos
Autores principales: Win, Khine Nwe, Manopwisedjaroen, Khajohnpong, Phumchuea, Kanit, Suansomjit, Chayanut, Chotivanich, Kesinee, Lawpoolsri, Saranath, Cui, Liwang, Sattabongkot, Jetsumon, Nguitragool, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701414/
https://www.ncbi.nlm.nih.gov/pubmed/36437462
http://dx.doi.org/10.1186/s12936-022-04382-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701414/
https://www.ncbi.nlm.nih.gov/pubmed/36437462
http://dx.doi.org/10.1186/s12936-022-04382-5

Ejemplares similares